DiRaimondo Thomas (CIK 0002005618)

Latest company ownership

JANX - Janux Therapeutics, Inc.
Role: Chief Scientific Officer
Shares held
84,000
Last filed at
Jan 3, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 27, 2024 Sep 27, 2024 Janux Therapeutics, Inc. Chief Scientific Officer Sell 37.5 -5,000 -4.86% ✓ $231.7K